カテゴリー： Market Monitor Global, 世界, 医療/バイオ

バイオシミラー&バイオ後続品の世界市場見通し2023年-2029年

◆英語タイトル：Biosimilars & Follow-on-Biologics Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5717）

◆商品コード：MMG23JU5717
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Biosimilars & Follow-on-Biologics Market 調査レポートは次の情報を含め、グローバルにおけるのバイオシミラー&バイオ後続品市場規模と予測を収録しています。・世界のバイオシミラー&バイオ後続品市場：売上、2018年-2023年、2024年-2029年
・世界のバイオシミラー&バイオ後続品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のバイオシミラー&バイオ後続品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ヒト成長ホルモン」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

バイオシミラー&バイオ後続品のグローバル主要企業は、Novartis、 Synthon Pharmaceuticals、 Teva Pharmaceutical Industries、 LG Life Sciences、 Celltrion、 Biocon、 Hospira、 Merck Group、 Biogen idec, Inc.、 Genentech (Roche Group)などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、バイオシミラー&バイオ後続品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のバイオシミラー&バイオ後続品市場：タイプ別、2018年-2023年、2024年-2029年
世界のバイオシミラー&バイオ後続品市場：タイプ別市場シェア、2022年
・ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他

世界のバイオシミラー&バイオ後続品市場：用途別、2018年-2023年、2024年-2029年
世界のバイオシミラー&バイオ後続品市場：用途別市場シェア、2022年
・血液疾患、腫瘍疾患、慢性&自己免疫疾患、成長ホルモン欠乏症、その他

世界のバイオシミラー&バイオ後続品市場：地域・国別、2018年-2023年、2024年-2029年
世界のバイオシミラー&バイオ後続品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるバイオシミラー&バイオ後続品のグローバル売上、2018年-2023年
・主要企業におけるバイオシミラー&バイオ後続品のグローバル売上シェア、2022年
・主要企業におけるバイオシミラー&バイオ後続品のグローバル販売量、2018年-2023年
・主要企業におけるバイオシミラー&バイオ後続品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Synthon Pharmaceuticals、 Teva Pharmaceutical Industries、 LG Life Sciences、 Celltrion、 Biocon、 Hospira、 Merck Group、 Biogen idec, Inc.、 Genentech (Roche Group)

*************************************************************

・調査・分析レポートの概要
バイオシミラー&バイオ後続品市場の定義
市場セグメント
世界のバイオシミラー&バイオ後続品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のバイオシミラー&バイオ後続品市場規模
世界のバイオシミラー&バイオ後続品市場規模：2022年 VS 2029年
世界のバイオシミラー&バイオ後続品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのバイオシミラー&バイオ後続品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のバイオシミラー&バイオ後続品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他
バイオシミラー&バイオ後続品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：血液疾患、腫瘍疾患、慢性&自己免疫疾患、成長ホルモン欠乏症、その他
バイオシミラー&バイオ後続品の用途別グローバル売上・予測

・地域別市場分析
地域別バイオシミラー&バイオ後続品市場規模 2022年と2029年
地域別バイオシミラー&バイオ後続品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Synthon Pharmaceuticals、 Teva Pharmaceutical Industries、 LG Life Sciences、 Celltrion、 Biocon、 Hospira、 Merck Group、 Biogen idec, Inc.、 Genentech (Roche Group)
...

This report aims to provide a comprehensive presentation of the global market for Biosimilars & Follow-on-Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars & Follow-on-Biologics. This report contains market size and forecasts of Biosimilars & Follow-on-Biologics in global, including the following market information:
Global Biosimilars & Follow-on-Biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biosimilars & Follow-on-Biologics Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Biosimilars & Follow-on-Biologics companies in 2022 (%)
The global Biosimilars & Follow-on-Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Human Growth Hormone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biosimilars & Follow-on-Biologics include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilars & Follow-on-Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars & Follow-on-Biologics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Biosimilars & Follow-on-Biologics Market Segment Percentages, by Type, 2022 (%)
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Global Biosimilars & Follow-on-Biologics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Biosimilars & Follow-on-Biologics Market Segment Percentages, by Application, 2022 (%)
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Global Biosimilars & Follow-on-Biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Biosimilars & Follow-on-Biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars & Follow-on-Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biosimilars & Follow-on-Biologics revenues share in global market, 2022 (%)
Key companies Biosimilars & Follow-on-Biologics sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Biosimilars & Follow-on-Biologics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilars & Follow-on-Biologics, market overview.
Chapter 2: Global Biosimilars & Follow-on-Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Biosimilars & Follow-on-Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilars & Follow-on-Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biosimilars & Follow-on-Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Biosimilars & Follow-on-Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars & Follow-on-Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars & Follow-on-Biologics Overall Market Size
2.1 Global Biosimilars & Follow-on-Biologics Market Size: 2022 VS 2029
2.2 Global Biosimilars & Follow-on-Biologics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biosimilars & Follow-on-Biologics Sales: 2018-2029
3 Company Landscape
3.1 Top Biosimilars & Follow-on-Biologics Players in Global Market
3.2 Top Global Biosimilars & Follow-on-Biologics Companies Ranked by Revenue
3.3 Global Biosimilars & Follow-on-Biologics Revenue by Companies
3.4 Global Biosimilars & Follow-on-Biologics Sales by Companies
3.5 Global Biosimilars & Follow-on-Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biosimilars & Follow-on-Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biosimilars & Follow-on-Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars & Follow-on-Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biosimilars & Follow-on-Biologics Market Size Markets, 2022 & 2029
4.1.2 Human Growth Hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal Antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.1.8 Peptide
4.1.9 Others
4.2 By Type – Global Biosimilars & Follow-on-Biologics Revenue & Forecasts
4.2.1 By Type – Global Biosimilars & Follow-on-Biologics Revenue, 2018-2023
4.2.2 By Type – Global Biosimilars & Follow-on-Biologics Revenue, 2024-2029
4.2.3 By Type – Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
4.3 By Type – Global Biosimilars & Follow-on-Biologics Sales & Forecasts
4.3.1 By Type – Global Biosimilars & Follow-on-Biologics Sales, 2018-2023
4.3.2 By Type – Global Biosimilars & Follow-on-Biologics Sales, 2024-2029
4.3.3 By Type – Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
4.4 By Type – Global Biosimilars & Follow-on-Biologics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biosimilars & Follow-on-Biologics Market Size, 2022 & 2029
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.1.6 Others
5.2 By Application – Global Biosimilars & Follow-on-Biologics Revenue & Forecasts
5.2.1 By Application – Global Biosimilars & Follow-on-Biologics Revenue, 2018-2023
5.2.2 By Application – Global Biosimilars & Follow-on-Biologics Revenue, 2024-2029
5.2.3 By Application – Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
5.3 By Application – Global Biosimilars & Follow-on-Biologics Sales & Forecasts
5.3.1 By Application – Global Biosimilars & Follow-on-Biologics Sales, 2018-2023
5.3.2 By Application – Global Biosimilars & Follow-on-Biologics Sales, 2024-2029
5.3.3 By Application – Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
5.4 By Application – Global Biosimilars & Follow-on-Biologics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biosimilars & Follow-on-Biologics Market Size, 2022 & 2029
6.2 By Region – Global Biosimilars & Follow-on-Biologics Revenue & Forecasts
6.2.1 By Region – Global Biosimilars & Follow-on-Biologics Revenue, 2018-2023
6.2.2 By Region – Global Biosimilars & Follow-on-Biologics Revenue, 2024-2029
6.2.3 By Region – Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
6.3 By Region – Global Biosimilars & Follow-on-Biologics Sales & Forecasts
6.3.1 By Region – Global Biosimilars & Follow-on-Biologics Sales, 2018-2023
6.3.2 By Region – Global Biosimilars & Follow-on-Biologics Sales, 2024-2029
6.3.3 By Region – Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.4.2 By Country – North America Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.4.3 US Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.4.4 Canada Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.4.5 Mexico Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.5.2 By Country – Europe Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.5.3 Germany Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.4 France Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.5 U.K. Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.6 Italy Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.7 Russia Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.8 Nordic Countries Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.9 Benelux Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.6.2 By Region – Asia Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.6.3 China Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.4 Japan Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.5 South Korea Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.6 Southeast Asia Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.7 India Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.7.2 By Country – South America Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.7.3 Brazil Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.7.4 Argentina Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.8.3 Turkey Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8.4 Israel Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8.5 Saudi Arabia Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8.6 UAE Biosimilars & Follow-on-Biologics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Biosimilars & Follow-on-Biologics Major Product Offerings
7.1.4 Novartis Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Company Summary
7.2.2 Synthon Pharmaceuticals Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Major Product Offerings
7.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.2.5 Synthon Pharmaceuticals Key News & Latest Developments
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Company Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.4 LG Life Sciences
7.4.1 LG Life Sciences Company Summary
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Major Product Offerings
7.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.4.5 LG Life Sciences Key News & Latest Developments
7.5 Celltrion
7.5.1 Celltrion Company Summary
7.5.2 Celltrion Business Overview
7.5.3 Celltrion Biosimilars & Follow-on-Biologics Major Product Offerings
7.5.4 Celltrion Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Celltrion Key News & Latest Developments
7.6 Biocon
7.6.1 Biocon Company Summary
7.6.2 Biocon Business Overview
7.6.3 Biocon Biosimilars & Follow-on-Biologics Major Product Offerings
7.6.4 Biocon Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Biocon Key News & Latest Developments
7.7 Hospira
7.7.1 Hospira Company Summary
7.7.2 Hospira Business Overview
7.7.3 Hospira Biosimilars & Follow-on-Biologics Major Product Offerings
7.7.4 Hospira Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Hospira Key News & Latest Developments
7.8 Merck Group
7.8.1 Merck Group Company Summary
7.8.2 Merck Group Business Overview
7.8.3 Merck Group Biosimilars & Follow-on-Biologics Major Product Offerings
7.8.4 Merck Group Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Merck Group Key News & Latest Developments
7.9 Biogen idec, Inc.
7.9.1 Biogen idec, Inc. Company Summary
7.9.2 Biogen idec, Inc. Business Overview
7.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Major Product Offerings
7.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.9.5 Biogen idec, Inc. Key News & Latest Developments
7.10 Genentech (Roche Group)
7.10.1 Genentech (Roche Group) Company Summary
7.10.2 Genentech (Roche Group) Business Overview
7.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Major Product Offerings
7.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.10.5 Genentech (Roche Group) Key News & Latest Developments
8 Global Biosimilars & Follow-on-Biologics Production Capacity, Analysis
8.1 Global Biosimilars & Follow-on-Biologics Production Capacity, 2018-2029
8.2 Biosimilars & Follow-on-Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars & Follow-on-Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars & Follow-on-Biologics Supply Chain Analysis
10.1 Biosimilars & Follow-on-Biologics Industry Value Chain
10.2 Biosimilars & Follow-on-Biologics Upstream Market
10.3 Biosimilars & Follow-on-Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars & Follow-on-Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Biosimilars & Follow-on-Biologics in Global Market
Table 2. Top Biosimilars & Follow-on-Biologics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Biosimilars & Follow-on-Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Biosimilars & Follow-on-Biologics Revenue Share by Companies, 2018-2023
Table 5. Global Biosimilars & Follow-on-Biologics Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Biosimilars & Follow-on-Biologics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Biosimilars & Follow-on-Biologics Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Biosimilars & Follow-on-Biologics Product Type
Table 9. List of Global Tier 1 Biosimilars & Follow-on-Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Biosimilars & Follow-on-Biologics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Biosimilars & Follow-on-Biologics Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Biosimilars & Follow-on-Biologics Sales (K Pcs), 2018-2023
Table 15. By Type - Global Biosimilars & Follow-on-Biologics Sales (K Pcs), 2024-2029
Table 16. By Application – Global Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Biosimilars & Follow-on-Biologics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Biosimilars & Follow-on-Biologics Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Biosimilars & Follow-on-Biologics Sales (K Pcs), 2018-2023
Table 20. By Application - Global Biosimilars & Follow-on-Biologics Sales (K Pcs), 2024-2029
Table 21. By Region – Global Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Biosimilars & Follow-on-Biologics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Biosimilars & Follow-on-Biologics Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Biosimilars & Follow-on-Biologics Sales (K Pcs), 2018-2023
Table 25. By Region - Global Biosimilars & Follow-on-Biologics Sales (K Pcs), 2024-2029
Table 26. By Country - North America Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Sales, (K Pcs), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Biosimilars & Follow-on-Biologics Product Offerings
Table 48. Novartis Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Synthon Pharmaceuticals Company Summary
Table 51. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Product Offerings
Table 52. Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Synthon Pharmaceuticals Key News & Latest Developments
Table 54. Teva Pharmaceutical Industries Company Summary
Table 55. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Product Offerings
Table 56. Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Teva Pharmaceutical Industries Key News & Latest Developments
Table 58. LG Life Sciences Company Summary
Table 59. LG Life Sciences Biosimilars & Follow-on-Biologics Product Offerings
Table 60. LG Life Sciences Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. LG Life Sciences Key News & Latest Developments
Table 62. Celltrion Company Summary
Table 63. Celltrion Biosimilars & Follow-on-Biologics Product Offerings
Table 64. Celltrion Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Celltrion Key News & Latest Developments
Table 66. Biocon Company Summary
Table 67. Biocon Biosimilars & Follow-on-Biologics Product Offerings
Table 68. Biocon Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Biocon Key News & Latest Developments
Table 70. Hospira Company Summary
Table 71. Hospira Biosimilars & Follow-on-Biologics Product Offerings
Table 72. Hospira Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Hospira Key News & Latest Developments
Table 74. Merck Group Company Summary
Table 75. Merck Group Biosimilars & Follow-on-Biologics Product Offerings
Table 76. Merck Group Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Merck Group Key News & Latest Developments
Table 78. Biogen idec, Inc. Company Summary
Table 79. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Product Offerings
Table 80. Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Biogen idec, Inc. Key News & Latest Developments
Table 82. Genentech (Roche Group) Company Summary
Table 83. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Product Offerings
Table 84. Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. Genentech (Roche Group) Key News & Latest Developments
Table 86. Biosimilars & Follow-on-Biologics Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 87. Global Biosimilars & Follow-on-Biologics Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Biosimilars & Follow-on-Biologics Production by Region, 2018-2023 (K Pcs)
Table 89. Global Biosimilars & Follow-on-Biologics Production by Region, 2024-2029 (K Pcs)
Table 90. Biosimilars & Follow-on-Biologics Market Opportunities & Trends in Global Market
Table 91. Biosimilars & Follow-on-Biologics Market Drivers in Global Market
Table 92. Biosimilars & Follow-on-Biologics Market Restraints in Global Market
Table 93. Biosimilars & Follow-on-Biologics Raw Materials
Table 94. Biosimilars & Follow-on-Biologics Raw Materials Suppliers in Global Market
Table 95. Typical Biosimilars & Follow-on-Biologics Downstream
Table 96. Biosimilars & Follow-on-Biologics Downstream Clients in Global Market
Table 97. Biosimilars & Follow-on-Biologics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biosimilars & Follow-on-Biologics Segment by Type in 2022
Figure 2. Biosimilars & Follow-on-Biologics Segment by Application in 2022
Figure 3. Global Biosimilars & Follow-on-Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Biosimilars & Follow-on-Biologics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Biosimilars & Follow-on-Biologics Revenue, 2018-2029 (US$, Mn)
Figure 7. Biosimilars & Follow-on-Biologics Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Biosimilars & Follow-on-Biologics Revenue in 2022
Figure 9. By Type - Global Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 11. By Type - Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 12. By Type - Global Biosimilars & Follow-on-Biologics Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 15. By Application - Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 16. By Application - Global Biosimilars & Follow-on-Biologics Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 20. By Region - Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 21. By Country - North America Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 22. By Country - North America Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 23. US Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 28. Germany Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 29. France Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 37. China Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 41. India Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 43. By Country - South America Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 44. Brazil Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
Figure 48. Turkey Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Biosimilars & Follow-on-Biologics Revenue, (US$, Mn), 2018-2029
Figure 52. Global Biosimilars & Follow-on-Biologics Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Biosimilars & Follow-on-Biologics by Region, 2022 VS 2029
Figure 54. Biosimilars & Follow-on-Biologics Industry Value Chain
Figure 55. Marketing Channels

※参考情報

バイオシミラーおよびバイオ後続品は、現代の医薬品開発において重要な役割を果たしている概念です。これらの製品は、医療現場における治療法を革新する可能性を秘めており、特にコストの面でのメリットも期待されています。ここでは、バイオシミラーとバイオ後続品について、それぞれの定義や特徴、種類、用途、関連技術などを詳しく述べます。

まず、バイオシミラーとは、既存のバイオ医薬品（オリジナルの生物製剤）に非常に類似した性質を持つ生物製剤のことを指します。これらは、オリジナル製品が特許の期限を迎えた後に市場に投入されることが一般的です。バイオシミラーは、オリジナル製品と同等の品質、安全性、効果を持つとされ、治療分野における競争を促進し、医療コストの抑制につながることが期待されています。

次に、バイオ後続品は、バイオシミラーに似ていますが、その特異な位置付けがあります。バイオ後続品は、オリジナルのバイオ医薬品の特許切れ後に開発された製品であり、やはり同様に特定の病気や症状の治療に用いられますが、バイオシミラーとは異なり、オリジナル製品を完全に模倣するわけではなく、異なる製造プロセスや成分を用いている場合があります。

これらの製品に共通する特徴として、まず製造工程が挙げられます。バイオ医薬品は生物学的な原料を用いて構築されるため、製造プロセスや条件により微細な性質の違いが生じることがあります。そのため、品質や特性を厳密に比較する必要があり、バイオシミラーは科学的な証拠に基づいてオリジナル製品と同等であることを示さなければなりません。

バイオシミラーの開発は、臨床試験を通じて行われ、オリジナル製品と同じ効果を示すことが求められます。また、製品の安定性や副作用のプロファイルについても徹底した評価が必要です。これに対して、バイオ後続品は、その設計や製造過程において独自性を持っているため、オリジナル製品に類似した効果を持つ一方、異なる特性を持つことが許容されるのが特徴です。

バイオシミラーやバイオ後続品の種類は多岐にわたります。例えば、モノクローナル抗体、ホルモン製剤、細胞治療製品、ワクチンなど様々なカテゴリーに分類されます。モノクローナル抗体は特に頻繁にバイオシミラーとして開発される傾向があります。例えば、がん治療に用いられるトラスツズマブ（商品名ハーツー）に対するバイオシミラーが多数登場しています。

用途に関しては、バイオシミラーは主に慢性疾患、自免疫疾患、がん治療などに用いられます。これにより患者の治療選択肢が広がり、より経済的な治療を受けられる可能性が高まります。バイオシミラーによって医薬品の価格が下がることは、保険制度や患者負担の軽減に寄与することが期待されます。

関連技術としては、製造技術や分析技術が重要です。バイオ医薬品の開発には、バイオリアクターや特定の細胞株の利用、高度なペプチド合成技術などが関与します。また、品質管理や特性評価には、質量分析やエライザ法、X線結晶構造解析などの科学的手法が利用されます。これらの技術は、バイオシミラーやバイオ後続品の開発過程に不可欠であり、新しい治療法の発展を支えています。

バイオシミラーとバイオ後続品の開発は、規制当局による厳格な監視下で行われます。たとえば、欧州連合（EU）やアメリカ食品医薬品局（FDA）にはそれぞれバイオシミラーに関するガイドラインが存在し、安全性と有効性を確保するための基準が設けられています。これにより、市場に投入されるバイオシミラーは、オリジナル製品と同等であることが科学的に示されなければなりません。

今後の展望として、バイオシミラーやバイオ後続品は、ますます多数の病気に対する治療において普及していくと考えられます。また、これらの製品は、特に発展途上国においても利用されるようになり、医療アクセスの向上に貢献することが期待されています。

結論として、バイオシミラーとバイオ後続品は、医薬品市場における重要な要素であり、さまざまな疾患に対する治療法の新たな選択肢を提供します。その開発には高い技術力が求められ、今後の医療の充実に寄与する可能性を秘めています。技術の進展とともに、これらの製品が患者の生活を向上させることに期待が寄せられています。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ バイオシミラー&バイオ後続品の世界市場見通し2023年-2029年(Biosimilars & Follow-on-Biologics Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

バイオシミラー&バイオ後続品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp